TABLE 11. Incidence rates* and percentages† of invasive cervical cancer, by demographic and tumor characteristics — United States,§ 2010–2014.
Demographic characteristic | No. | Rate (95% CI) |
---|---|---|
Total
|
61,499
|
7.5 (7.5–7.6)
|
Age group at diagnosis (yrs)
| ||
<40 |
15,061 |
3.9 (3.8–3.9) |
40–49 |
15,242 |
14.3 (14.1–14.6) |
50–59 |
13,551 |
12.3 (12.1–12.6) |
60–69 |
9,538 |
11.6 (11.3–11.8) |
70–79 |
5,003 |
10.4 (10.1–10.7) |
≥80 |
3,104 |
8.6 (8.3–8.9) |
Race
| ||
White |
47,007 |
7.3 (7.2–7.4) |
Black |
9,837 |
9.3 (9.1–9.5) |
American Indian/Alaska Native |
609 |
6.5 (6.0–7.1) |
Asian/Pacific Islander |
2,900 |
6.1 (5.9–6.3) |
Ethnicity¶
| ||
Hispanic |
10,236 |
9.7 (9.5–9.9) |
Non-Hispanic |
51,259 |
7.3 (7.2–7.3) |
County classification
| ||
Metropolitan |
50,808 |
7.4 (7.4–7.5) |
Nonmetropolitan |
8,440 |
8.4 (8.2–8.6) |
Census region
| ||
Northeast |
10,935 |
7.1 (6.9–7.2) |
Midwest |
12,530 |
7.1 (7.0–7.3) |
South |
25,587 |
8.3 (8.2–8.4) |
West |
12,447 |
6.9 (6.8–7.0) |
Tumor characteristic**
|
No.
|
%
|
Total
|
59,726
|
100.0
|
Histology
| ||
Squamous cell carcinoma |
39,480 |
66.1 |
Adenocarcinoma |
16,456 |
27.6 |
Epithelial carcinoma, NOS |
2,235 |
3.7 |
All other histologies |
1,555 |
2.6 |
Stage††
| ||
Localized |
26,183 |
43.8 |
Regional |
21,650 |
36.2 |
Distant |
8,824 |
14.8 |
Unknown | 3,069 | 5.1 |
Abbreviations: CI = confidence interval; NOS = not otherwise specified.
* New cases diagnosed per 100,000 females, age adjusted to the 2000 U.S. standard population.
† New cases diagnosed.
§ Cancer incidence data were compiled from cancer registries that met the data quality criteria for all invasive cancer sites combined, representing approximately 99% of the U.S. population. (Data from Nevada did not meet U.S. Cancer Statistics publication criteria for 2010–2014.)
¶ Ethnicity is not mutually exclusive from race.
** Only includes microscopically confirmed cases; excludes cases identified only through death certificate or autopsy report.
†† Localized: cancer that is confined to the primary site; regional: cancer that has spread directly beyond the primary site or to regional lymph nodes; distant: cancer that has spread to other organs.